Director/PDMR Shareholding
4basebio PLC announced that its Chief Executive Officer, Dr. Amy Walker, acquired 2,650 ordinary shares on February 13, 2026, for an aggregated purchase price of 586.08 pence per share. This transaction increases her total shareholding to 46,666 ordinary shares, representing 0.30% of the company's issued share capital, which comprises 15,538,518 ordinary shares. The purchase of these shares, which constitute approximately 0.02% of the company's issued share capital, is considered inside information.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
– 4basebio PLC (AIM: 4BB), an innovation driven biotechnology company enabling and accelerating development of advanced therapy medicinal products (ATMPs) through its high performant GMP-grade synthetic DNA products, announces that on 13 February 2026 it was informed that Dr. Amy Walker, Chief Executive Officer of the Company made the following purchase in ordinary shares in the capital of the Company through the market.
Further details are set out in the Notification of Dealing Form below.
| Director / PCA | Number of Ordinary Shares Acquired | Purchase Price (Aggregated) (p) | Shareholding Following Acquisition | Shareholding Following Acquisition as a Percentage of Issued Share Capital |
|---|---|---|---|---|
| Dr. Amy Walker | 2,650 | 586.08 | 46,666 | 0.30% |
The 2,650 shares purchased represent approximately 0.02 per cent. of the Company's issued share capital.
The issued share capital of the Company comprises 15,538,518 ordinary shares.
| a) | Name | Dr. Amy Walker | ||||
| 2 | Reason for the notification | |||||
| a) | Position/Status | Chief Executive Officer | ||||
| b) | Initial notification/ Amendment | Initial notification | ||||
| a) | Name | 4basebio plc | ||||
| b) | LEI | 213800E2DX9EAIUNCB30 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares ISIN: GB00BMCLYF79 | ||||
| b) | Nature of the transaction | Acquisition of ordinary shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated Price | 2,650 586.08p | ||||
| e) | Date of transaction | 13 February 2026 | ||||
| f) | Place of transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.